The pancreas's storage signal
Insulin blood testing measures the hormone insulin circulating in your bloodstream. Insulin is made by beta cells in the pancreas (pancreatic islet β‑cells). It is produced from a larger precursor (proinsulin) and released together with its companion fragment (C‑peptide). When you eat and blood sugar rises, signals from glucose and gut hormones (incretins) prompt these cells to secrete insulin. The test captures that circulating signal at a given moment.
Insulin's job is to move fuel into cells and keep blood sugar steady. It tells muscle and fat to take up glucose, signals the liver to store rather than make glucose, and shifts the body toward building glycogen, fats, and proteins (anabolism) while damping breakdown (catabolism). Because of these actions, circulating insulin reflects how strongly the pancreas is responding to nutrients and how responsive tissues are to the hormone (insulin sensitivity). In short, insulin is the body's post‑meal traffic controller for energy, and the blood test is a readout of that control signal.
Why fasting insulin sees trouble before glucose does
Insulin is the body's storage signal. Made by the pancreas, it tells liver, muscle, and fat cells when to take up glucose, store energy, and quiet down glucose release. An insulin blood test shows how hard your pancreas is working to keep blood sugar normal and how sensitive your tissues are to insulin—a window into metabolism, weight regulation, liver fat, blood pressure, and reproductive hormones. Fasting values typically sit in a low, narrow range; "within reference ranges" tends to be at the lower end of normal. After meals, insulin should rise and then settle back within a few hours.
An insulin blood test measures how much of the hormone insulin your pancreas is releasing into the bloodstream. It is a direct readout of the body's control system for moving glucose into cells, storing fuel, and keeping blood sugar steady. Because insulin also influences fat handling, blood pressure, inflammation, brain signaling, and reproductive hormones, it is a core marker of whole‑body metabolism.
Interpreting low, in-range, and high fasting insulin
Very low fasting insulin can simply reflect high insulin sensitivity or prolonged fasting, with steady energy and easy glucose control. When insulin is low despite high glucose, it signals deficiency—classically type 1 diabetes or advanced beta‑cell exhaustion—leading to unchecked liver glucose output, fat breakdown, and ketone production. Symptoms include thirst, frequent urination, weight loss, and fatigue; children are particularly prone to rapid dehydration and ketoacidosis. In pregnancy, true insulin deficiency is uncommon and concerning.
Low values usually reflect either very effective insulin action (high insulin sensitivity) or impaired pancreatic output (beta‑cell dysfunction). When glucose is normal, low insulin often means your tissues need little hormone to do the job. When glucose is high but insulin is low, it suggests insufficient secretion, which can lead to poor energy delivery to muscle and brain and rising blood sugars. In children and lean young adults, very low insulin with high glucose raises concern for autoimmune beta‑cell loss.
Being in range suggests appropriate basal secretion and a coordinated response between pancreas, liver, muscle, and fat. With normal glucose, many clinicians view low‑normal fasting insulin as a sign of efficient insulin signaling and stable cardiometabolic function.
Higher fasting insulin points to insulin resistance: the pancreas overproduces insulin to keep glucose normal. This drives liver fat and high triglycerides, lowers HDL, raises blood pressure via sodium retention, and fuels hunger and fatigue after meals. Darkened neck/axillary skin (acanthosis) may appear. In women, ovarian androgen excess can cause irregular cycles and features of PCOS; in men, low SHBG and sexual dysfunction can occur. Teens have a physiologic bump in resistance; pregnancy increases resistance as well, and excessive levels suggest risk for gestational diabetes and larger babies.
High values usually reflect the pancreas compensating for insulin resistance in muscle and liver (compensatory hyperinsulinemia). This state promotes liver fat production, higher triglycerides, sodium retention and sympathetic tone (raising blood pressure), and can alter brain appetite signals. In women, excess insulin can drive ovarian androgen production and cycle irregularity. Rarely, high insulin accompanies low glucose from an insulin‑secreting tumor (insulinoma).
What changes the insulin reading
Interpretation depends on fasting vs post‑meal timing and on paired glucose and C‑peptide. Puberty and pregnancy physiologically raise insulin. Kidney or liver impairment reduces clearance. Glucocorticoids, atypical antipsychotics, and acute illness increase insulin demand. Assays vary and may not equally detect insulin analogs.
An earlier metabolic warning than glucose
Big picture: insulin integrates energy balance, liver health, vascular tone, and reproductive function. Abnormal insulin often precedes abnormal glucose, foreshadowing metabolic syndrome, fatty liver, type 2 diabetes, and cardiovascular disease. Measuring insulin alongside glucose markers clarifies early risk and whole‑system health.
FAQs
It’s a blood test that measures the concentration of insulin, providing insight into glucose handling, energy regulation, and metabolic risk.
Testing helps detect early insulin resistance, understand appetite and energy patterns, and track the impact of nutrition, activity, sleep, and stress over time.
Start with a baseline and retest periodically to follow trends, especially when making changes to diet, training, sleep, or stress.
Dietary intake, exercise, medications, stress, sleep, and underlying health conditions can all shift insulin; consider these factors when interpreting results.
Fasting is commonly required for fasting insulin measurements; always follow the instructions provided with your test.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. https://doi.org/10.1007/BF00280883
- Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Frontiers in Endocrinology, 14, 1149239. https://doi.org/10.3389/fendo.2023.1149239
- Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. The New England Journal of Medicine, 362(9), 800-811. https://doi.org/10.1056/NEJMoa0908359
- American Diabetes Association Professional Practice Committee. (2024). 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2024. Diabetes Care, 47(Suppl 1), S20-S42. https://doi.org/10.2337/dc24-S002
- Sánchez-García, A., Rodríguez-Gutiérrez, R., Mancillas-Adame, L., González-Nava, V., Díaz González-Colmenero, A., Solis, R. C., Álvarez-Villalobos, N. A., & González-González, J. G. (2020). Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review. International Journal of Endocrinology, 2020, 4678526. https://doi.org/10.1155/2020/4678526






































.avif)
